Multi-Drug Resistance in Cancer (Hardcover)

Lingua: inglese

Editore: John Wiley & Sons Inc, New York, 2023

1394209215 / 9781394209217

Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

Venditore con 5 stelle

Venditore AbeBooks dal 12 ottobre 2005

Rilegato

Condizione: Nuovo

EUR 187,81

 Spedizione gratuita 
Spedito in U.S.A.

Quantità: 1 disponibile

Aggiungi al carrello
Resi gratuiti per 30 giorni

Descrizione dell’articolo da parte del venditore

Hardcover. MULTI-DRUG RESISTANCE IN CANCER The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents. Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases. Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance. The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment. Audience This book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancers multi-drug resistance. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Codice articolo 9781394209217

Titolo
Multi-Drug Resistance in Cancer (Hardcover)
Autore
Rishabha Malviya
Editore
John Wiley & Sons Inc, New York
Anno di pubblicazione
2023
Condizione
new
Rilegatura
Hardcover
Lingua
inglese
ISBN 10
1394209215
ISBN 13
9781394209217

Grand Eagle Retail

Bensenville, IL, U.S.A.

Venditore con 5 stelle

Venditore AbeBooks dal 12 ottobre 2005

Tariffe di spedizione nazionale per U.S.A.

ArticoloDa 6 a 14 giorni lavorativiDa 6 a 16 giorni lavorativi
Primo articoloEUR 0,00EUR 0,00
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.

Metodi di pagamento

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Informazioni sull’azienda del venditore

APOLLO ONLINE CORP.

605 Geddes Street
Wilmington, DE U.S.A. 19805